K. L. Blackwell

A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy

J. O’Shaughnessy, K. L. Blackwell, Harold J. Burstein et al. · Journal of Clinical Oncology · 2008 · 157 citations

Breast Oncology, Immunology, Pathology +18

Neratinib in combination with trastuzumab for the treatment of advanced breast cancer: A phase I/II study

Ramona F. Swaby, K. L. Blackwell, Zefei Jiang et al. · Journal of Clinical Oncology · 2009 · 87 citations

Advanced Breast Cancer, Part 1, Oncology +14

Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.

K. L. Blackwell, Zishan A. Haroon, Saijun Shan et al. · PubMed · 2000 · 81 citations

Angiogenesis, Medicine, Tumor Growth +13

Reconstruction of the Laryngopharynx After Hemicricoid/Hemithyroid Cartilage Resection: Preliminary Functional Results

Mark L. Urken, K. L. Blackwell, Hugh F. Biller · Archives of Otolaryngology - Head and Neck Surgery · 1997 · 56 citations

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification

Zahid N. Rabbani, Matthew E. Hardee, S J Kim et al. · British Journal of Cancer · 2012 · 51 citations · Full text